| Name | Title | Contact Details |
|---|
We are a biopharmaceutical company developing first-in-class therapies for cancer. Imetelstat, a novel, first-in-class telomerase inhibitor, is our product candidate in clinical development. Telomerase enables cancer cells to maintain telomere length, which provides them with the capacity for limitless cellular replication. Imetelstat is a potent and specific inhibitor of telomerase. Based on clinical data we obtained in late 2012, we may develop imetelstat to treat one or more hematologic myeloid malignancies such as myelofibrosis, or MF, myelodysplastic syndromes, or acute myelogenous leukemia.
Find a barre3® studio near you or subscribe to barre3 Online and start an online workout today.
Outlook Associates, Inc. is a Irvine, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
MSC Group is a Jacksonville, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
VisualMED Clinical Solutions Corp. is a Outremont, QC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.